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Summary
Background: Cell-cell adhesion and intracellular trafficking
are regulated by signaling pathways from small GTPases of
the Rho, Arf, and Rab subfamilies. How signaling from distinct
small GTPases are integrated in a given process is poorly
understood.
Results: We find that a TBC/RabGAP protein, Armus, inte-
grates signaling between Arf6, Rac1, and Rab7 during junction
disassembly. Armus binds specifically to activated Rac1 and
its C-terminal TBC/RabGAP domain inactivates Rab7. Thus,
Armus is a novel Rac1 effector and a bona fide GAP for Rab7
in vitro and in vivo, a unique and previously unreported combi-
nation. Arf6 activation efficiently disrupts cell-cell contacts
and is known to activate Rac1 and Rab7. Arf6-induced
E-cadherin degradation is efficiently blocked by expression
of Armus C-terminal domain or after Armus RNAi. Coexpres-
sion of Arf6 with dominant-negative Rab7 or Rac1 also inhibits
junction disassembly. Importantly, Armus RabGAP expression
also prevents EGF-induced scattering in keratinocytes, a
process shown here to require Arf6, Rac1, and Rab7 function.
To our knowledge, this is the first report to demonstrate
a molecular and functional link between Rac1 and Rab7.
Conclusions: Our data indicate that active Rac1 recruits
Armus to locally inactivate Rab7 and facilitate E-cadherin
degradation in lysosomes. Thus, the integration of Rac1 and
Rab7 activities by Armus provides an important regulatory
node for E-cadherin turnover and stability of cell-cell contacts.
Introduction
Small GTPases of the Rho, Arf, and Rab families are essential
regulators of many important cellular processes. Although*Correspondence: v.braga@imperial.ac.uk
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overlap. For example, Rho, Rab, and Arf small GTPases are
known to regulate proliferation, intracellular trafficking, migra-
tion, and attachment to substrata or neighboring cells [1–6]. In
spite of the importance of these cellular processes for homeo-
stasis and disease, the molecular mechanisms of how
signaling from different GTPases is coordinated are not fully
understood.
Destabilization of cell-cell contacts in epithelial cells is one
such process in which multiple small GTPases play a role.
Cell-cell adhesion mediated by E-cadherin receptors is a key
event in the regulation of epithelial morphogenesis, differenti-
ation, and function [4, 7]. Perturbation of epithelial junctions
results in acquisition of mesenchymal characteristics, with
increased proliferation and motility [2, 4]. Thus, an appropriate
control of E-cadherin adhesion and surface levels is important
for many aspects of epithelial function in health and disease.
Activation of Rac1 and Arf6 destabilize E-cadherin receptors
from junctions in different cell types, upon which cells detach
from epithelial sheets [8, 9]. This phenotype is part of a wide
range of Rac1 and Arf6 functions during tumor progression
including hyperproliferation, rearrangement of the cytoskel-
eton, and invasion [2, 4]. Rac1 activation is sufficient to perturb
cell-cell adhesion by itself or when activated by Ras and other
oncogenes [10–12]. A number of reports suggest that Rac1 is
activated downstream of Arf6 and is necessary to promote
cytoskeletal changes and cell motility [2, 5, 13]. Yet, conflicting
evidence exists as to whether Rac1 is required downstream of
Arf6 to perturb cell-cell contacts. For example, Arf6 activation
in MDCK cells results in a transient decrease in Rac1 activity,
which correlates temporally with junction breakdown [14].
The molecular mechanisms leading to junction disassembly
have not been fully elucidated. One possibility is the involve-
ment of Rabs, which regulate the dynamics of internaliza-
tion/recycling of adhesive receptors such as cadherins and
integrins [1, 13]. Upon expression of oncogenes or growth
factor stimulation, the function of Rab5 is required for cadherin
internalization/recycling, thereby effectively reducing its
surface levels and cell-cell adhesion [1]. Inappropriate activa-
tion of Rac1 leads to increased internalization of E-cadherin
receptors and their accumulation in intracellular vesicles [10,
11]. However, the specific Rabs required downstream of
Rac1 are not known.
Arf6-induced junction disassembly may also involve
a cross-talk with Rab GTPases, even though Arf6 per se can
regulate endocytosis and exocytosis [2]. In MDCK cells, v-
Src-induced activation of Arf6 perturbs cadherin adhesion in
a Rab5- and Rab7-dependent manner [15]. Consistent with
the above, expression of active Arf6 [8] or its activation by v-
Src [15] promotes accumulation of E-cadherin in intracellular
vesicles [9, 15].
The existence of distinct pathways controlled by Arf6, Rac1,
and Rab small GTPases in the regulation of cadherin adhesion
cannot be formally excluded. However, most likely there are
nodes of interaction between pathways regulated by these
small GTPases to efficiently modulate cadherin surface levels.
Mechanistically, these nodes could be indirect (1) through
modulation of phosphoinositide production [2, 13] or (2)
Figure 1. Armus Is a Novel Rac1 Binding Protein
(A) Representation of the domain structure of Armus and truncation mutants used in this study. Amino acid region of each mutant is shown in subscript and
the domains contained in each fragment are also shown. The clone isolated in the yeast two-hybrid screen represents the first 550 amino acids of Armus
(Armus1-550). PH, Pleckstrin Homology domain; C, coiled-coil domains; RabGAP, TBC/RabGAP domain.
(B) Yeast two-hybrid binding assay with Armus1-550 and activated forms of RhoA (Rho
Q63L), Rac1 (RacQ61L), Cdc42 (Cdc42Q61L), and empty vector (pACTII).
RhoGAP and WASP were used as positive controls.
(C) Pull-down assay with GST-fusion proteins (activated RacQ61L, Cdc42Q61L, or RhoQ63L) and in vitro translated (IVT) myc-Armus1-550, myc-WASP, and
myc-Rhophilin (positive controls for Cdc42 and RhoA binding, respectively).
(D) GST-RacQ61L was incubated with different IVT Armus fragments as described on the top of the panel.
(E and F) Activated GST-Rac1 (Rac1Q61L or Rac1G12V mutations) or wild-type (RacWT) loaded with GTPgS or GDP were incubated with IVT myc-Armus1-550 (E)
or myc-Armus295-433 (F). Data representative of three independent experiments, thereafter referred to as n = 3. Input represents 10% of amount used in
pull-downs. See also Figure S1.
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activity to vesicles/plasma membrane (i.e., p85, BAR, and PH
domains found in upstream regulators) [16]. Alternatively,
nodes to integrate signaling by different small GTPases may
be direct, via multiple domains in a single protein. This single
protein would have the ability to interact with a particular small
GTPase in a GTP-dependent manner and have domains to
activate or downregulate a distinct small GTPase. For
example, ALS2/alsin can interact with active Rac1 and induce
Rab5 activation [17, 18]. Other examples are ARAP (contains
ArfGAP and RhoGAP domains—GAP, GTPase activating
protein), p50RhoGAP (interacts with Rab11 and inactivates
Rho) [19], Arfaptin (binds to active Arf1/Arf6 and inactive
Rac1), and ARGHGAP10 (interacts with active Arf1 and is
a Cdc42 GAP) [5, 16]. Yet, the vast numbers of small GTPases
and their overlapping cellular functions imply that further
nodes of interconnection between their activities must exist.
Thus, although a cross-talk between signaling from Rac1,
Rab, and Arf6 may occur in different cellular processes, the
precise molecular mechanisms have not yet been unravelled.Here we provide new mechanistic insights into a cross-talk
between these small GTPases during disassembly of cell-cell
contacts. We identify the function of an uncharacterized
protein, Armus, a member of the TBC/RabGAP family (Tre2/
Bub2/Cdc16; TBC domain) [20]. Armus contains an unusual
and previously unreported combination of domains: it inter-
acts with activated Rac1 via a novel motif and at the C terminus
contains a TBC/RabGAP domain. Importantly, Armus plays
a key role in EGF-induced scattering and Arf6-dependent
disassembly of junctions, by integrating Rac1 activation with
Rab7 function to promote E-cadherin degradation.
Results
Identification and Characterization of a Novel Rac-Binding
Protein
By using activated Rac1 as bait, we have identified a novel
Rac1 binding protein after a yeast two-hybrid screen with
a normal human keratinocyte cDNA library (Figure 1A). The
yeast two-hybrid clone specifically bound to activated Rac1,
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200but not active RhoA or Cdc42 (Figure 1B). A single 3.9 kb
mRNA species was identified in keratinocyte RNA samples,
but multiple bands were observed in epithelia-containing
organs in human multitissue northern blots (Figures S1A and
S1B available online). The full-length cDNA was cloned with
RT-PCR and normal keratinocyte total RNA: it includes a pre-
dicted PH domain, coiled-coil domains in the middle and at the
C terminus, and a putative TBC/RabGAP domain [16, 20] (here-
after referred to as the RabGAP domain; Figure 1A).
The isolated clone (928 amino acids, hereafter referred to as
aa) is homologous to a member of TBC/RabGAP family,
TBC1D2 isoform A (860 aa), and identical to its variant c (928
aa), but contains polymorphisms at three different sites
(Figure S1C). Armus is also highly homologous to PARIS-1
(917 aa), a protein overexpressed in prostate cancers that
contains a deletion of 11 amino acids [21], suggesting that
the deletion could be specific for prostate tumors. Consistent
with a number of sequences containing TBC/RabGAP
domains, additional homologous EST sequences may be iso-
forms or truncation mutants isolated from different organs or
tumor samples (V.M.M.B., unpublished data). Because of the
widespread Armus distribution in different tissues (Figure S1B)
and the distinct, more complete sequence than PARIS-1, we
named the protein Armus (meaning ‘‘hinge, linker’’ in Latin
[armus] and ancient Greek [armys]). According to the well-
accepted function-based approach to name proteins, the
name reflects the novel function of Armus as a linker between
active Rac1 and Rab signaling pathways via the RabGAP
domain [16].
The ability of Armus to interact specifically with activated
Rac1 was confirmed in vitro by pull downs with in vitro trans-
lated Armus and immobilized active Rac1, RhoA, or Cdc42
(Figure 1C). The binding site for Rac1 is present at Armus
N-terminal region, central coiled-coil domains (Armus295-433,
Figure 1D), which contains no sequences similar to CRIB
motifs or other Rac-binding domains [22]. Armus interaction
with wild-type Rac1 occurred in a GTP-dependent manner
(Figures 1E and 1F). The isolated coiled-coiled domains bound
more efficiently to active Rac when compared to Armus1-550
(Figures 1E and 1F), consistent with the binding properties of
other Rac targets [22].
Armus intracellular localization was quantified accordingly
to its presence/absence at keratinocyte junctions (Figure 2).
A proportion of exogenous PH domain (Armus1-169) localized
at cell-cell contacts in 73% of expressing cells, whereas the
C-terminal region localized in the cytoplasm and less effi-
ciently at junctions (Armus547-928; Figures 2A and 2B). In
contrast, although some faint junctional localization was
observed, Armus1-550 was mostly found at enlarged vesicles
in the cytoplasm that did not contain E-cadherin (Figures 2A
and 2B). It appeared that Armus is sequestered away from
junctions in cells in which vesicles are present. Interestingly,
distinct pools of full-length Armus (Armus1-928) were seen at
all intracellular localizations: cell-cell contacts, vesicles, and
cytoplasm (Figures 2A and 2B), suggesting that no spurious
localization was observed upon expression of truncation
mutants.
Antisera were raised against three different peptides from
Armus sequence and recognized a protein band of 105 KDa
from keratinocyte lysates (Figures S2A and S2B), which corre-
sponds to the predicted size of the full-length protein. Staining
of endogenous Armus with affinity-purified antibodies (IC2)
was faint, but clearly disappeared when antibodies were pre-
incubated with the peptide antigen (Figure 2C). A pool ofendogenous Armus localized at punctate structures in cyto-
plasm and at junctions in most keratinocytes (Figure 2C). Inter-
estingly, endogenous Armus was specifically coimmunopreci-
pitated with endogenous E-cadherin, but not a3 integrins
(Figure 2D and data not shown). As control, GIT1 [5], which
indirectly associates with Rac1, could not be coprecipitated
with E-cadherin complexes under these conditions (Figure 2D).
Surprizingly, Armus PH domain mediated the association with
cadherin complexes (Figure S2C). This result is consistent with
the preferential localization of Armus PH domain to junctions
(Figures 2A and 2B) and its inability to interact with lipids
(data not shown). Our results indicate that a direct or indirect
interaction with cadherin complexes may mediate Armus
localization at cell-cell contacts.Armus Is a Bona Fide GAP for Rab7
To directly test whether Armus RabGAP domain is functional,
an in vitro GAP assay was performed on different Rabs (Fig-
ure 3A; Figure S3). Armus RabGAP domain potently enhanced
the intrinsic GTP hydrolysis of Rab7, a Rab that regulates late
endosomal transport and lysosomal biogenesis [6]. Deletion of
the last C-terminal amino acids of Rab7 (Rab7D22) had no effect
on the ability of Armus to potentiate GTP hydrolysis on Rab7.
Because no increase in hydrolysis was observed on other
Rabs tested (Figure 3A), the above results strongly suggest
that Armus RabGAP may be a GAP specific for Rab7. A caveat
of the above assay (10 min time point) is that fast-hydrolyzing
GTPases such as Rab5 cannot be formally excluded as
substrate for Armus. Clearly, further work should extend the
repertoire of Rab proteins to test for additional substrates of
Armus RabGAP.
We next measured the activity of Rab7 in vivo by using the
ability of its effector RILP to specifically interact with
Rab7.GTP [23]. Expression of Armus C terminus significantly
reduced the amount of active GFP-Rab7WT precipitated by
GST-RILP (Figure 3B), suggesting that Armus inactivates
Rab7 in vivo. Conversely, inhibition of Rac1 by dominant-
negative RacT17N elevated the active levels of endogenous
Rab7 (Figure 3C), indicating that Rac regulates endogenous
Rab7 activation, a previously unreported function of Rac1.
Taken together, our data convincingly argue that Armus Rab-
GAP is able to inactivate Rab7 in vitro and in vivo. However,
participation of Armus in other trafficking events cannot be
formally excluded at this stage (see below).Armus Is Required for Arf6-Induced Junction Disassembly
Armus association with cadherin complexes and localization
at junctions suggests a putative function at cell-cell contacts
(Figure 2). We investigated Arf6-induced destabilization of
E-cadherin adhesion, because it is known to activate Rac1
and Rab7 [2, 15], two small GTPases functionally linked to
Armus. Expression of activated Arf6 potently removed E-cad-
herin from keratinocyte cell-cell contacts and induced the
accumulation of junctional components at a perinuclear local-
ization (Figure 4; see also Figures 5A, 6A, and 6B). Similar
events were observed with slower kinetics when a fast-cycling
Arf6 mutant [24] was expressed (Figures S4A–S4C). Upon
active Arf6 expression, endogenous Armus disappeared
from junctions and a pool colocalized with internalized E-cad-
herin at the perinuclear compartment (Figure 4, see also
Figure S4D for exogenous Armus). In contrast, the lysosomal
markers LAMP1 and CD63 were recruited to, but remained
adjacent to, sites where E-cadherin accumulated (Figure 4).
Figure 2. Intracellular Localization of Armus
(A) Armus full-length (Armus1-928) and different truncation mutants were expressed in keratinocytes and their localization assessed by staining for endog-
enous E-cadherin and tagged constructs. Merged images are shown in the bottom panels. Inserts show amplification of the boxed areas.
(B) Quantification of the localization of exogenous Armus at sites of cell-cell contacts (presence/absence). Diagrams on the top of immunofluorescence
pictures (A) and at the side of the graph (B) show the domain structure of constructs used. Dashed lines represent faint junctional staining of Armus1-550.
(C) Affinity-purified IC2 antibodies (see also Figure S2) were used to stain endogenous Armus. IC2 preincubated with the antigen peptide (+peptide) or conju-
gate alone (conjugate) are shown as controls.
(D) Endogenous E-cadherin was immunoprecipitated from keratinocyte lysates, and the presence of endogenous Armus and GIT1 was assessed by western
blots.
Arrowheads show junctional localization; arrows point to enlarged vesicles. IF, immunofluorescence. Error bars represent standard error. n = 3 (except for
Armus1-550 where n = 8). Scale bar represents 16 mm or 32 mm for insets.
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Figure 3. Armus RabGAP Has Activity toward Rab7 In Vitro and In Vivo
(A) GTP hydrolysis of wild-type versions of different Rabs was quantified in
the absence (intrinsic activity, 2 Armus547-928) or presence of Armus
C-terminal domain (+ Armus547-928). Values are expressed as relative GTP
content [(GTP)/(GTP + GDP)]. For fusion proteins used, refer to Figure S3.
(B and C) Determination of the activation status of Rab7 in vivo. Lysates
were prepared after expression of wild-type Rab7 (GFP-Rab7WT) alone or
in combination with Armus C-terminal region (flag-Armus547-928) (B) or after
inhibition of Rac1 (myc-Rac1T17N, C). Active Rab7 was quantified by pull-
down with GST-RILP (RILP pull-down). Expression of constructs or endog-
enous proteins was assessed with the antibodies shown on the right of
each panel. GST-RILP was detected by amido-black staining. Error bars
represent standard error. n = 3. *p < 0.00002; **p < 0.007.
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a separate study.
Interestingly, coexpression of activated Arf6 with Armus
C-terminal domain (WT) significantly prevented disruption of
cell-cell adhesion and changes in keratinocyte morphology
(Figures 5A and 5B), whereas an inactive Armus RabGAP
mutant (RE) was not effective (Figure 5B; Figure S5A). PAK is
a serine-threonine kinase that participates in many Rac func-
tions [3, 22]. In contrast to Armus RabGAP expression, inhibi-
tion of PAK did not rescue the destabilization of cadherins
induced by active Arf6 (PAKAID; Figure 5C). It is unlikely that
Armus C-terminal fragment could interfere with junction
perturbation by titrating out active small GTPases: it was not
able to interact with Rac1 or active Arf6 (Figure S5B and data
not shown). The above results suggest that Armus is down-
stream of Arf6 activation and is specifically required for junc-
tion destabilization.
To substantiate the above result, endogenous Armus was
efficiently depleted by RNAi (Figure 5D). After transfection of
active Arf6 and Armus depletion, the amount of intact junctions
increased 2-fold (Figure 5E; Figure S5C). The rescue obtained
after Armus siRNA was partial and smaller than that obtained
by expression of Armus C-terminal domain (Figure 5B). One
explanation is that all keratinocytes expressing Arf6 were
considered in the quantification. Thus, some cells might
have residual Armus and show junction disruption, thereby
lowering the rescue levels observed.Furthermore, depletion of Armus protein is predicted to (1)
remove the localized regulation/inactivation of Rab7 at vesi-
cles being targeted to lysosomes and (2) increase Rab7 activa-
tion overall (because a GAP specific for Rab7 is not present).
We interpret that the partial rescue effect of Armus depletion
on junctions may result from the balance of these two
responses. Whereas Armus RNAi may prevent the localized
regulation of Rab7 cycling, Armus RabGAP expression is pre-
dicted to block the increase in Rab7.GTP levels induced by
Arf6. Yet, both approaches can significantly rescue the
stability of cell-cell contacts.
Our results suggest that Armus may specifically modulate
E-cadherin transport to lysosomes by regulating Rab7 cycling.
Total and endocytosed levels of E-cadherin and b1-integrin
were determined after expression of different constructs
(Figures 5F and 5G; Figure S6). Levels of internalized proteins
were assessed by biotinylation of surface proteins on ice
(30 min) after 3.5 hr of transfection of the different constructs
(Figure 5G). After incubation at 37C for different time points
(1–5 hr), biotinylated surface proteins were stripped and
lysates prepared. Biotinylated internalized proteins were
precipitated with streptavidin-agarose and amount assessed
by blots (see Figure S6).
Active Arf6 potently induced degradation of E-cadherin
receptors (as shown by the reduction in total levels,
Figure 5F; Figure S6A), yet total levels of b1-integrin were not
affected (Figure S6C). Interestingly, coexpression of Arf6Q67L
and Armus RabGAP prevented E-cadherin degradation and
the observed increase in E-cadherin internalization (Figures
5F and 5G; Figure S6B). As controls, expression of GFP or
Armus C-terminal region containing the RabGAP domain did
not interfere with total levels or the internalized pool of E-cad-
herin (Figures 5F and 5G). Expression of Armus RabGAP or
GFP did not affect b1-integrin internalization pattern (Fig-
ure S6D), similarly to what observed with E-cadherin. We sur-
mise that a potential mechanism for the efficient rescue of
Arf6-dependent junction disruption by Armus547-928 may be
the inhibition of cadherin degradation via inactivation of Rab7.
Armus Mediates a Crosstalk between Rac1 and Rab7
We reasoned that Armus may bring together signaling mole-
cules that are relevant for perturbation of cell-cell adhesion
induced by Arf6 (i.e., Rac1 and Rab7). In contrast to MDCK
cells [14], when Arf6 was activated in keratinocytes, attenua-
tion of Rac1 signaling efficiently prevented the disassembly
of cadherin-dependent junctions (Figures 6A and 6C).
Inhibition of Rab7 (Rab7T22N) per se did not alter E-cadherin
stability, but significantly interfered with junction disruption
when coexpressed with active Arf6 (Figures 6B and 6D). In
contrast, inhibition of Rab1 was unable to prevent junction
disruption by Arf6 (Figure 6E), indicating the specificity for
Rab7. Therefore, preventing activation of Rab7 (by domi-
nant-negative Rab7T22N) or forcibly inactivating Rab7 (by Ar-
mus) potently interfered with Arf6-dependent E-cadherin
degradation.
In addition, Armus RabGAP expression or inhibition of Rac1
or Rab7 partially reversed the accumulation of E-cadherin at
the perinuclear region induced by active Arf6 (Figure 6F). It is
formally possible that Armus may also interfere with other
trafficking events. For example, expression of Armus RabGAP
redistributed vesicles induced by active Rab5 to the cell
periphery (Figure S7). Thus, although Armus RabGAP did not
appear to inactivate Rab5 (Figure 4A), it was clearly able to
modulate the distribution of Rab5-induced vesicles. The
Figure 4. Armus Accumulates at a Perinuclear Region when Active Arf6 Is Expressed
Activated Arf6 (HA-Arf6Q67L, 0.1 mg/ml) was expressed in keratinocytes for 3 hr. Cells were triple-labeled for HA-tag, E-cadherin, and endogenous Armus,
LAMP1, or CD63 as markers of lysosomes. Insets show enlargement of the boxed area. Arrowheads indicate vesicular compartment with accumulated
E-cadherin/Armus; arrows show recruited LAMP1 or CD63 staining. n = 3. Scale bar represents 16 mm or 32 mm for insets. See Figure S4 for supporting data.
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future work. Nevertheless, our results point to the key function
of Rac1 and Rab7 in the regulation of cadherin turnover down-
stream of Arf6.
To address whether Armus also participates in cadherin
degradation after a physiological stimulus, EGF-induced scat-
tering was performed in HaCaTs, a nontransformed keratino-
cyte cell line. Expression of Armus C-terminal region (WT)
reduced the ability to scatter in response to EGF, but not
when mutated to impair its GAP activity (RE; Figures 7A and
7B). EGF treatment induced activation of Rab7 (Rab7.GTP),
yet no changes were detected in Rab7 protein levels
(Figure 7C). EGF-dependent activation of Rab7 was counter-
acted by expression of Armus C-terminal domain, but not
the catalytic-deficient mutant (Figure 7C). Interestingly, block-
ing Arf6, Rac1, or Rab7 activation by dominant-negative
mutants also significantly prevented EGF scattering (Fig-
ure 7D). Our data strongly support the participation of Armus
and its functional partners in scattering induced by EGF.
Furthermore, our results indicate that a coordination of
signaling between Rac1 activation, its effector Armus, and
Rab7 cycling is required to ensure efficient destabilization of
E-cadherin adhesion and receptor degradation.
Discussion
A fundamental issue in signaling is how different small
GTPases cross-talk to each other in the regulation of a single
cellular process. Here, we characterize Armus, a TBC/Rab-
GAP-containing protein [16], that provides a potential mecha-
nism via which Rac1 can directly couple to Rab7 signaling andintracellular trafficking. The relevance of our findings is 3-fold:
(1) we show that Rac1 is able to regulate Rab7 function, a previ-
ously unknown cellular role for Rac; (2) Armus is a key mole-
cule to relay signals from active Rac1 to modulate Rab7
cycling; and (3) importantly, we have identified a function for
Armus in the regulation of E-cadherin turnover.
There are about 52 coding sequences predicted to contain
TBC/RabGAP domains in human databases [16]. The TCB/
RabGAP family has generated much interest [25, 26], because
the upstream regulation of Rab function is poorly understood
[6]. Moreover, RabGAP proteins have been implicated in
diseases such as Warburg microsyndrome [27] and different
types of cancers [21, 28, 29]. Apart from three polymorphic
sites, Armus is identical to the TBC1D2 isoform A variant
c and contains extra amino acids than PARIS-1, an isoform
overexpressed in prostate cancer [16, 21]. However, the func-
tion of these proteins is not known nor have their Rab
substrates and interacting partners been identified.
Armus has a unique combination of domains with the possi-
bility to integrate the function of different small GTPases.
Armus PH domain mediates localization at cell-cell contacts
and coprecipitates with cadherin complexes. The central
coiled-coil domains interact specifically with active Rac1 but
do not contain CRIB motifs, consistent with a subset of effec-
tors that bind exclusively to Rac [22]. Finally, a C-terminal TBC/
RabGAP domain contains a predicted arginine finger respon-
sible for catalysis [16, 30] and potently inactivates Rab7, an
important regulator of lysosomal biogenesis, in vivo and
in vitro. Although Armus does not appear to inactivate different
Rabs tested here, it is possible that further studies may unravel
additional Rab substrates.
Figure 5. Armus Functions Downstream of Arf6 during Disassembly of Cell-Cell Contacts
(A) Armus547-928 was expressed by itself or in combination with active Arf6
Q67L. Keratinocytes were fixed and stained for the respective tags and E-cadherin.
Arrowheads indicate intact junctions; arrow shows accumulation of intracellular E-cadherin. Scale bar represents 50 mm.
(B and C) Percentage of intact junctions in neighboring cells expressing Arf6Q67L alone or in combination with Armus547-928 (wild-type or RE mutant, B) or
PAK autoinhibitory domain (PAKAID, C). Armus RE mutant images are shown in Figure S5A.
(D) Keratinocytes were treated with different siRNA oligos, lysates prepared, and probed with antibodies shown on the left of panels.
(E) After Armus RNAi, cells were transfected with HA-Arf6Q67L and the percentage of intact junctions between neighboring, Arf6-expressing cells was quan-
tified as described in Experimental Procedures. Immunofluorescence images are shown in Figure S5C.
(F and G) After transfection of Arf6Q67L alone or in combination with Armus547-928 for 3.5 hr, cells were biotinylated and the total amount (F) and the inter-
nalized pool (G) of E-cadherin receptors were determined. Time is shown in hours after biotinylation. Expression of GFP was used as controls. Values
were normalized to the amount quantified at time 0 (t0); tX is the expression level observed in time X. Corrensponding western blots are shown in Figure S6.
Error bars represent standard error. n = 3. *p < 0.006; **p < 0.03; ***p < 0.014.
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somes because the release of a Rab from acceptor membranes
requires its inactivation [6]. To our knowledge, Rac1 has not
been previously implicated in Rab7 and lysosomal function. It
has been proposed that Rac1 participates in intracellular
trafficking indirectly, via reorganization of the cortical cytoskel-
eton or actin-dependent movement of vesicles [13]. However,
our data indicate that Rac1 signaling may interfere with traf-
ficking more directly by regulating Rab/Arf localization and
function, as shown previously [17, 18, 31]. Indeed, we show
here that inhibition of Rac1 can activate endogenous Rab7.
We suggest that Armus potentially modulates Rab7 activity at
sites in which active Rac1 is present (Figure 7E).
Rac1 is essential for Arf6-induced breakdown of epithelial
colonies, motility, and cytoskeletal rearrangements [8, 14, 24,
32]. Arf6 requires Rac1 activation for disruption of keratinocyte
junction (Figure 7E), in line with the ability of Arf6 to activate
Rac1 by different mechanisms [2]. However, our results differ
from MDCK cells because, in the latter, disassembly of cell-
cell contacts by Arf6 correlates with Rac1 downregulation
[14, 15]. This difference most likely reflects cell type-specific
regulation of junctions [4, 10, 12, 33].
We demonstrate that Armus is a key molecule to coordinate
Rac1 and Rab7 activities in the pathway Arf6 > Rac1 > Armus >
Rab7 (Figure 7E). In support of our model, junctiondestabilization induced by active Arf6 is efficiently rescued
upon interfering with the function of endogenous Rac1, Armus,
or Rab7 (Figure 7F). Our data suggest that Armus function on
cadherin adhesion is specific for Rab7 inactivation and as
a Rac1 effector: Armus does not sequester active Rac1 or
Arf6, and inhibition of Rab1 or PAK1, a Rac effector, cannot
block junction disassembly triggered by Arf6.
We envisage three potential mechanisms via which Armus
RabGAP expression maintains stable junctions after Arf6 acti-
vation (Figure 7F). First, coexpression of Armus RabGAP with
active Arf6 reduces the levels of internalized E-cadherin con-
siderably. However, at steady-state Armus RabGAP expres-
sion does not perturb E-cadherin levels or localization at junc-
tions. Moreover, Armus does not appear to inactivate Rab5 or
Rab11, Rabs that regulate endocytic/recycling transport [6,
13]. Yet, Armus RabGAP redistributes active Rab5-positive
vesicles to cell periphery, suggesting a potential regulation
of early trafficking events and/or cadherin endocytosis more
directly (Figure 7F).
Second, rescue of E-cadherin junctional levels by Armus
RabGAP expression may result indirectly from preventing
lysosomal targeting, thereby increasing E-cadherin recycling
to the surface (Figure 7F). Indeed, impairment of a trafficking
route can redirect proteins to different intracellular compart-
ments, i.e., surface levels/degradation of other receptors can
Figure 6. Rac1 and Rab7 Are Required Downstream of Arf6 to Perturb Cadherin Adhesion
(A and B) Expression of activated Arf6 (HA-Arf6Q67L), dominant-negative Rac1 (myc-RacT17N), or Rab7 (0.05 mg/ml, Rab7T22N) alone or in combination
was performed for 3 hr (A and B), after which cells were fixed and stained for the tags and E-cadherin. Rac1 signaling was attenuated, but not to sufficient
levels to disrupt cell-cell contacts [11]. Arrows point to accumulation of cadherin at perinuclear region; arrowheads show intact junctions. Scale bars repre-
sent 50 mm. See Figure S6 for effects of Armus RabGAP on Rab5-induced vesicles.
(C–E) Quantification of the percentage of cells containing intact junctions and expressing Arf6 alone or in combination with the dominant-negative
constructs: RacT17N (C), Rab7T22N (D), or Rab1S25N as control (E).
(F) Percentage of coexpressing cells containing perinuclear accumulation of E-cadherin after microinjection of Arf6Q67L alone or in combination with
Armus547-928, Rac
T17N, or Rab7T22N. Error bars represent standard error. nR 3. @p < 0.0004; *p < 0.0009; **p < 0.00001; ***p < 0.00002.
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interpretation is supported by two lines of evidence: (1) when
Armus is coexpressed with Arf6, cadherin receptors are not
degraded and accumulation of E-cadherin at the perinuclear
region is reduced; and (2) Rab7 inhibition per se is sufficient
to rescue dissociation of junctions very efficiently.
Third, it is reasonable that, by inhibiting Rab7 cycling and
lysosomal targeting, Armus RabGAP may induce Arf6-depen-
dent recycling of internalized cadherin receptors from perinu-
clear compartment back to junctions. Arf6 is known to regulate
both endocytosis and exocytosis [2] and has functional links
with Rab11, one of the Rabs responsible for recycling from
the perinuclear compartment [6]. Thus in our model, when
Armus RabGAP is expressed or Rab7 inhibited, Arf6 signaling
could be diverted to Rab11 to recycle receptors to the cell
surface (Figure 7F).
Regulation of early trafficking events and lysosomal delivery
downstream of Arf6 are not mutually exclusive possibilities. In
fact, they may be consistent with the localization of Armus at
junctions and perinuclear compartment where E-cadherin
accumulates. We surmise that a potential interference on early
trafficking events by Armus RabGAP may result from: (1) direct
inactivation of additional Rab family members, (2) indirectly
overloading intracellular transport by inhibition of lysosomal
function, or (3) alteration of Arf6 signaling favoring recycling.
Irrespective of the relative contribution of lysosomal delivery
versus increased endocytosis, our data strongly demonstrate
the involvement of Rac1, Armus, and Rab7 in cadherin turn-
over downstream of Arf6.
Interestingly, the pathway Arf6 > Rac1 > Armus > Rab7 also
operates during EGF-induced scattering of keratinocytes. EGFis an essential growth factor during epithelial morphogenesis
and homeostasis. Conversely, increased EGFR signaling
occurs in many different epithelia-derived tumors leading to
scattering, invasion, and poor prognosis [36]. Yet, the sig-
naling events downstream of EGF receptors that mediate cell
scattering are comparatively less understood than HGF-
induced scattering, for example. We demonstrate for the first
time the requirement of Arf6, Rac, and Rab7 as well as Armus
in EGF-dependent epithelial scattering. Our findings point out
to the potential widespread importance and physiological
significance of the pathway.
Our data underscore the complexity of the interplay
between signaling by different small GTPases and how dis-
secting the coordination of their activities at the molecular
level can further our knowledge. The participation of Arf6 [2,
37] and Rac1 activation [4] in different aspects of epithelial
tumorigenesis highlights the need to understand the molecular
mechanisms involved and identify suitable therapeutic
targets. Interestingly, Rab7 is overexpressed in adenomas
[38] and interfering with Rab7 function has been suggested
as a potential cancer therapy [39]. Armus-related proteins
are upregulated in different epithelial tumors (PARIS-1 [21]
and other truncated versions; data not shown), although their
precise role (and consequence of deletions) remains to be es-
tablished. Taken together with our data, there is a strong case
that Armus-regulated pathway(s) may be important in E-cad-
herin degradation to facilitate metastasis during tumorigen-
esis. Because stable junctional E-cadherin is essential for
epithelial homeostasis, our data have significant implications
for tumor dedifferentiation and progression. Armus may be
a good candidate to block epithelial dedifferentiation during
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Figure 7. EGF-Induced Scattering Requires Armus Function in Keratinocytes
(A) HaCaT cells were transfected with Armus C-terminal domain (Armus547-928, wild-type [WT], or catalytic inactive mutant [RE]), induced to scatter by treat-
ment with EGF, fixed, and stained for the tag (expression) and E-cadherin. Arrows indicate a reduction of E-cadherin staining in cells beginning to scatter;
arrowhead points to increased E-cadherin at junctions comparable to control nonexpressing cells. Scale bar represents 50 mm.
(B) Quantification of the number of scattered HaCaTs after EGF treatment as described in (A).
(C) HaCaT cells were treated as described in (A), and lysates were prepared to determine active Rab7 levels via RILP pull-down. Endogenous Rab7 and
Armus547-928 expression were detected with antibodies shown on the right of the panel; GST-RILP was detected with amido black staining.
(D) Quantification of the number of scattered HaCaTs after treatment with EGF and expression of dominant-negative Arf6T27N, RacT17N, Rab7T22N constructs.
(E and F) Diagram summarizing our results.
(E) Expression of activated Arf6 or treatment with EGF in keratinocytes destabilizes E-cadherin adhesion and Arf6 promotes cadherin accumulation at a peri-
nuclear region. Armus localizes at junctions and, after Arf6 activation, also accumulates at the perinuclear compartment. Active Arf6 induces Rac1 activa-
tion, Armus recruitment, and modulation of Rab7 cycling to allow degradation of E-cadherin in lysosomes.
(F) Expression of Armus RabGAP, inhibition of Arf6, Rac1, or Rab7 (respective dominant-negative constructs, shown by asterisk) prevents EGF-dependent
degradation of E-cadherin in lysosomes. We hypothesize that, by forcibly inactivating Rab7, Armus RabGAP perturbs lysosomal targeting of cadherins and
favors recycling of the receptors to cell surface/junctions or divert Arf6-dependent signaling to recycling (dashed lines). Error bars represent standard error.
nR 3. @p < 0.008; *p < 0.0007; **p < 0.0004; ***p < 0.002.
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cadherin degradation.Experimental Procedures
Cells
Normal human keratinocytes isolated from neonatal foreskin were cultured
as described previously [40]. For RNAi experiments, keratinocytes were
grown in low calcium medium [40]. HaCaT (immortalized keratinocytes)
and COS-7 cells were cultured in Dulbecco’s modified Eagle medium(DMEM, Sigma) containing 10% FCS and 5 mM glutamine. For scattering
assays, HaCaTs were seeded in coverslips (1 3 104 cells) and cultured until
small colonies were formed (4–8 cells). After transfection and expression for
24 hr, HaCaT cells were stimulated with 100 nM EGF in serum-free media
containing 0.1% fatty acid-free BSA and incubated for 24 hr. For biotinyla-
tion assays, normal keratinocytes were seeded on 24-well plates and grown
until 70% confluence.
Determination of Rab7 Activity Levels In Vivo
After expression of different constructs for 24 hr, HaCaT cells were lysed in
lysis buffer (20 mM HEPES [pH 7.4], 150 mM NaCl, 1% NP-40, 2.5 mM MgCl2,
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207and 1 mM of each protease inhibitor PMSF, leupeptin, pepstatin, and pefa-
bloc). Lysates were cleared by centrifugation at 14,000 rpm at 4C for 5 min
and incubated for 1 hr with RILP-GST beads at 4C for 1 hr. After washing
three times with washing buffer (same composition as above but without
NP-40), beads were collected and proteins attached to beads were probed
by western blotting. To detect endogenous Rab7 activation, cells were
transfected with active HA-Arf6 or treated with EGF (100 mM in same media)
for 24 hr in the presence or absence of different Armus constructs, then
lysed and processed as above.
Quantifications
Quantification of the localization of Armus constructs at cadherin-depen-
dent cell-cell contacts was performed with the following criteria. Cells
were scored positive if exogenous Armus colocalized with cadherins and
calculated relative to the total number of expressing cells (arbitrarily set
as 100%). For quantification of junction disruption, only cell-cell contacts
between two expressing cells were considered. Arf6-induced junction
disruption was assessed by scoring cell-cell contacts between two ex-
pressing cells as intact (when cadherin staining was present). Values were
shown as a percentage of total junctions between expressing cells. For
scattering assays, only expressing cells at the periphery of epithelial colo-
nies were counted (not single, isolated cells). Cells were scored as scat-
tering if E-cadherin was absent from junctions, a reduction in the levels of
junctional E-cadherin was observed, or cell shape was fusiform when
compared to controls. Error bars represent standard error of the means.
Statistics were calculated by Student’s t test.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/
j.cub.2009.12.053.
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